Takeda To Move Tokyo HQBy
Takeda Pharmaceutical Company has signed an agreement with Takashimaya Company to sell the Tokyo Takeda Building, the company’s current Tokyo headquarters, and the Takeda Shin-Edobashi Building. Takeda is globally headquartered in Osaka, Japan.
The sale price is 49.5 billion yen ($439.6 million), and Takeda plans to book a pre-tax gain of approximately 39 billion yen ($346 million) in the second half of fiscal year 2018. The transfer of the real estate will be completed by the end of March 2019.
The Tokyo Takeda Building was completed in 1966 as Takeda’s Tokyo Branch/Sales Office to accommodate the expansion of business operations. In 1984, the building also became Takeda’s Tokyo headquarters. Takeda is currently constructing a new Tokyo Headquarters, the Shin-Tokyo Takeda Building (provisional name), in Nihonbashi-Honcho, Tokyo and plans to relocate there upon completion in the spring of 2018.
Source: Takeda Pharmaceutical Company